✦ LIBER ✦

KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?

✍ Scribed by Basavarajappa, Halesha D; Corson, Timothy W

Book ID: 120391700
Publisher: Future Science
Year: 2012
Tongue: English
Weight: 917 KB
Volume: 4
Category: Article
ISSN: 1756-8919
DOI: 10.4155/fmc.12.158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The TWEAK/Fn14 as a novel therapeutic ta

The TWEAK/Fn14 as a novel therapeutic target for cutaneous lupus erythematosus

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Dendritic cells in Asthma: A target for

Dendritic cells in Asthma: A target for novel therapeutics?

✍ Leonie S. van Rijt; Bart N. Lambrecht 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 754 KB

Fibroblast growth factor receptor 1 onco

Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer

✍ Yuria Mano; Koji Takahashi; Nobuhisa Ishikawa; Atsushi Takano; Wataru Yasui; Kou 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 688 KB

The role of STATs in lung carcinogenesis

The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics

✍ Michalis V. Karamouzis; Panagiotis A. Konstantinopoulos; Athanasios G. Papavassi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 254 KB

Exome sequencing identifies mutations in

Exome sequencing identifies mutations in KIF14 as a novel cause of an autosomal recessive lethal fetal ciliopathy phenotype

✍ Filges, I.; Nosova, E.; Bruder, E.; Tercanli, S.; Townsend, K.; Gibson, W.T.; Rö 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

[Handbook of Experimental Pharmacology]

[Handbook of Experimental Pharmacology] Protein-Protein Interactions as New Drug Targets Volume 186 || An Oncogenic Hub: β-Catenin as a Molecular Target for Cancer Therapeutics

✍ Klussmann, Enno; Scott, John 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 217 KB

Disease-relevant intracellular protein-protein interactions occurring at defined cellular sites possess great potential as drug targets. They permit highly specific pharmacological interference with defined cellular functions. Drugs targeting such interactions are likely to act with fewer side effec